Molecular viability testing of bacterial pathogens from a complex human sample matrix.
Assays for bacterial ribosomal RNA precursors (pre-rRNA) have been shown to distinguish viable from inactivated bacterial cells in drinking water samples. Because the synthesis of pre-rRNA is rapidly induced by nutritional stimulation, viable bacteria can be distinguished from inactivated cells and free nucleic acids by measuring the production of species-specific pre-rRNA in samples that have been briefly stimulated with nutrients. Here, pre-rRNA analysis was applied to bacteria from serum, a human sample matrix. In contrast to drinking water, serum is rich in nutrients that might be expected to mask the effects of nutritional stimulation. Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) assays were used to detect pre-rRNA of four bacterial species: Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, and the Mycobacterium tuberculosis complex. These species were chosen for their clinical significance and phylogenetic diversity (Proteobacteria, Firmicutes, and Actinobacteria). To maximize resolving power, pre-rRNA was normalized to genomic DNA of each pathogen. When viable cells were shifted from serum to bacteriological culture medium, rapid replenishment of pre-rRNA was always observed. Cells of P. aeruginosa that were inactivated in the presence of serum exhibited no pre-rRNA response to nutritional stimulation, despite strong genomic DNA signals in these samples. When semi-automated methods were used, pre-rRNA analysis detected viable A. baumannii cells in serum at densities of ≤100 CFU/mL in <5.5 hours. Originally developed for rapid microbiological analysis of drinking water, ratiometric pre-rRNA analysis can also assess the viability of bacterial cells derived from human specimens, without requiring bacteriological culture.
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, United States of America.
Kris M
KM
Weigel
Kelly L
KL
Jones
Julie S
JS
Do
Jody
J
Melton Witt
Jae-Hyun
JH
Chung
Christian
C
Valcke
Gerard A
GA
Cangelosi
D040981:Acinetobacter baumannii / Q000235:genetics / Q000302:isolation & purification; D015169:Colony Count, Microbial; D003470:Culture Media; D004269:DNA, Bacterial / Q000097:blood*; D006801:Humans; D050296:Microbial Viability; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000235:genetics / Q000302:isolation & purification; D012322:RNA Precursors / Q000097:blood*; D012329:RNA, Bacterial / Q000097:blood*; D044967:Serum / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000235:genetics / Q000302:isolation & purification
D003470:Culture Media; D004269:DNA, Bacterial; D012322:RNA Precursors; D012329:RNA, Bacterial